41
Building Partnerships for Precision Medicine FHIR® and the FHIR Icon are trademarks of HL7, Inc. (h9p://hl7.org) Presented by: Gil Alterovitz, PhD and Charles Jaffe, MD, PhD 1 CoChair, HL7 Clinical Genomics Workgroup and Lead, SMART on FHIR Genomics. Assistant Prof., HMS and CHIP@BCH. 2 HL7 InternaOonal Chief ExecuOve Officer

Building(Partnershipsfor(( Precision(Medicine...Precision medicine is an emerging approach for disease treatment and prevention that takes into account individual variability in genes,

  • Upload
    others

  • View
    6

  • Download
    0

Embed Size (px)

Citation preview

Page 1: Building(Partnershipsfor(( Precision(Medicine...Precision medicine is an emerging approach for disease treatment and prevention that takes into account individual variability in genes,

Building  Partnerships  for    Precision  Medicine  

FHIR®  and  the  FHIR  Icon  are  trademarks  of  HL7,  Inc.  (h9p://hl7.org)  

Presented  by:    

Gil  Alterovitz,  PhD  and  Charles  Jaffe,  MD,  PhD  1Co-­‐Chair,  HL7  Clinical  Genomics  Workgroup  and  Lead,  SMART  

on  FHIR  Genomics.    Assistant  Prof.,  HMS  and  CHIP@BCH.  2HL7  InternaOonal  Chief  ExecuOve  Officer  

 

Page 2: Building(Partnershipsfor(( Precision(Medicine...Precision medicine is an emerging approach for disease treatment and prevention that takes into account individual variability in genes,

Precision medicine is an emerging approach for disease treatment and prevention that takes into account individual variability in genes, environment, and lifestyle for each person.

FHIR  Genomics  Tutorial  14Jan2016   2

Page 3: Building(Partnershipsfor(( Precision(Medicine...Precision medicine is an emerging approach for disease treatment and prevention that takes into account individual variability in genes,

® Health  Level  Seven  and  HL7  are  registered  trademarks  of  Health  Level  Seven  Interna;onal,  registered  with  the  United  States  Patent  and  Trademark  Office.  

The  Problem  

How  do  we  enable  Precision  Medicine  at  point  of  care?      

3  

Page 4: Building(Partnershipsfor(( Precision(Medicine...Precision medicine is an emerging approach for disease treatment and prevention that takes into account individual variability in genes,

Precision  Medicine  IniOaOve®  Cohort  Program  RFA  

4

Page 5: Building(Partnershipsfor(( Precision(Medicine...Precision medicine is an emerging approach for disease treatment and prevention that takes into account individual variability in genes,

® Health  Level  Seven  and  HL7  are  registered  trademarks  of  Health  Level  Seven  Interna;onal,  registered  with  the  United  States  Patent  and  Trademark  Office.  

HL7  Standards:  V2,  V3,  CDA,  FHIR  

§  V2-­‐  lots  of  implementaOons  §  V3-­‐  nice  models,  few  implementaOons  §  CDA-­‐  document  (V3-­‐based,  Reference  InformaOon  Model)  

§  FHIR-­‐  lots  of  excitement,  emerging  standard,  standard  for  trial  use.  

5

Page 6: Building(Partnershipsfor(( Precision(Medicine...Precision medicine is an emerging approach for disease treatment and prevention that takes into account individual variability in genes,

® Health  Level  Seven  and  HL7  are  registered  trademarks  of  Health  Level  Seven  Interna;onal,  registered  with  the  United  States  Patent  and  Trademark  Office.  

HL7  V2  Example  from  InsLtute  of  Medicine  (IOM)  

§  People  metabolize  drugs  at  different  rates  based  on  genes  (e.g.  TPMT  for  Azathioprine,  an  immunosuppressant  given  to  prevent  transplant  rejecOon)  

§  By  determining  TPMT  acOvity,  amount  of  drug  given  for  parOcular  paOent  can  be  opOmized  to  reduce  toxicity  

§  IOM  guide  stated  how  to  communicate  such  results  via  HL7  v2  ObservaOon  (and  gave  pointers  for  how  to  do  it  in  FHIR  as  well)  

6

Page 7: Building(Partnershipsfor(( Precision(Medicine...Precision medicine is an emerging approach for disease treatment and prevention that takes into account individual variability in genes,

® Health  Level  Seven  and  HL7  are  registered  trademarks  of  Health  Level  Seven  Interna;onal,  registered  with  the  United  States  Patent  and  Trademark  Office.   7

Page 8: Building(Partnershipsfor(( Precision(Medicine...Precision medicine is an emerging approach for disease treatment and prevention that takes into account individual variability in genes,

® Health  Level  Seven  and  HL7  are  registered  trademarks  of  Health  Level  Seven  Interna;onal,  registered  with  the  United  States  Patent  and  Trademark  Office.   8

Page 9: Building(Partnershipsfor(( Precision(Medicine...Precision medicine is an emerging approach for disease treatment and prevention that takes into account individual variability in genes,

® Health  Level  Seven  and  HL7  are  registered  trademarks  of  Health  Level  Seven  Interna;onal,  registered  with  the  United  States  Patent  and  Trademark  Office.   9

(Azathioprine)

(thiopurine S-methyltransferase) TPMT Location: 6p22.3

Cytotoxicity

Page 10: Building(Partnershipsfor(( Precision(Medicine...Precision medicine is an emerging approach for disease treatment and prevention that takes into account individual variability in genes,

® Health  Level  Seven  and  HL7  are  registered  trademarks  of  Health  Level  Seven  Interna;onal,  registered  with  the  United  States  Patent  and  Trademark  Office.   10

Page 11: Building(Partnershipsfor(( Precision(Medicine...Precision medicine is an emerging approach for disease treatment and prevention that takes into account individual variability in genes,

® Health  Level  Seven  and  HL7  are  registered  trademarks  of  Health  Level  Seven  Interna;onal,  registered  with  the  United  States  Patent  and  Trademark  Office.  

V3  

11

Page 12: Building(Partnershipsfor(( Precision(Medicine...Precision medicine is an emerging approach for disease treatment and prevention that takes into account individual variability in genes,

® Health  Level  Seven  and  HL7  are  registered  trademarks  of  Health  Level  Seven  Interna;onal,  registered  with  the  United  States  Patent  and  Trademark  Office.  

Hughes  RiskApps:    Less  work  +  CDS=Higher  Quality  

Patient enters data into Tablet PC

Reviews Intuitive Report & suggested management Genetic Testing

Patient educational materials

Risk Engine WebService

HL7 V3 è FHIR Genomics

Courtesy: Dr. Kevin Hughes, MGH

Page 13: Building(Partnershipsfor(( Precision(Medicine...Precision medicine is an emerging approach for disease treatment and prevention that takes into account individual variability in genes,

® Health  Level  Seven  and  HL7  are  registered  trademarks  of  Health  Level  Seven  Interna;onal,  registered  with  the  United  States  Patent  and  Trademark  Office.   13

Page 14: Building(Partnershipsfor(( Precision(Medicine...Precision medicine is an emerging approach for disease treatment and prevention that takes into account individual variability in genes,

® Health  Level  Seven  and  HL7  are  registered  trademarks  of  Health  Level  Seven  Interna;onal,  registered  with  the  United  States  Patent  and  Trademark  Office.  

Pedigree/Breast  Cancer  Risk  

14

Page 15: Building(Partnershipsfor(( Precision(Medicine...Precision medicine is an emerging approach for disease treatment and prevention that takes into account individual variability in genes,

® Health  Level  Seven  and  HL7  are  registered  trademarks  of  Health  Level  Seven  Interna;onal,  registered  with  the  United  States  Patent  and  Trademark  Office.  

Clinical  Document  Architecture  (CDA)  

15

Page 16: Building(Partnershipsfor(( Precision(Medicine...Precision medicine is an emerging approach for disease treatment and prevention that takes into account individual variability in genes,

® Health  Level  Seven  and  HL7  are  registered  trademarks  of  Health  Level  Seven  Interna;onal,  registered  with  the  United  States  Patent  and  Trademark  Office.  

GeneLc  Test  Report  

16

Page 17: Building(Partnershipsfor(( Precision(Medicine...Precision medicine is an emerging approach for disease treatment and prevention that takes into account individual variability in genes,

® Health  Level  Seven  and  HL7  are  registered  trademarks  of  Health  Level  Seven  Interna;onal,  registered  with  the  United  States  Patent  and  Trademark  Office.  17

GTR  -­‐  Design  Principles  §  Follow  exisOng  report  formats  commonly  used  in  healthcare  &  research  

 §  Emphasize  interpretaOons  &  recommendaOons  

   §  Provide  general  background  informaOon  on  tests  performed    

 §  Reference  HL7  Clinical  Genomics  instances  (e.g.,  v3  or  v2  GeneOcVariaOon  

and  Pedigree)  as  the  place  holders  of  full-­‐blown  raw  genomic  data  and  fully-­‐structured  family  history  data  

§  UOlize  pa9erns  of  ‘genotype-­‐phenotype’  associaOons  in  the  HL7  v3  Clinical  Genomics  Domain  

–  Implement them as ‘clinical genomic statement’ entry-level templates (see next slide), enabling meaningful use of the data

Courtesy: Amnon Shabo

Page 18: Building(Partnershipsfor(( Precision(Medicine...Precision medicine is an emerging approach for disease treatment and prevention that takes into account individual variability in genes,

® Health  Level  Seven  and  HL7  are  registered  trademarks  of  Health  Level  Seven  Interna;onal,  registered  with  the  United  States  Patent  and  Trademark  Office.  18

GTR  Overall  Layout  

Courtesy: Amnon Shabo

Page 19: Building(Partnershipsfor(( Precision(Medicine...Precision medicine is an emerging approach for disease treatment and prevention that takes into account individual variability in genes,

® Health  Level  Seven  and  HL7  are  registered  trademarks  of  Health  Level  Seven  Interna;onal,  registered  with  the  United  States  Patent  and  Trademark  Office.  

SMART/FHIR  Genomics  

19

Page 20: Building(Partnershipsfor(( Precision(Medicine...Precision medicine is an emerging approach for disease treatment and prevention that takes into account individual variability in genes,

SMART  on  FHIR  Genomics  

20  

General Features: •  FHIR clinical profiles aligned to MU2 •  Patient record scope/authorization •  Authentication/Single-Sign on •  UI integration layer to launch within EMR

Page 21: Building(Partnershipsfor(( Precision(Medicine...Precision medicine is an emerging approach for disease treatment and prevention that takes into account individual variability in genes,

SMART  on  FHIR  Genomics  

21  

Genomic-Specific Features: •  Genomics integrated directly into clinical model •  First in FHIR DSTU 2.0, latest is tested FHIR

Connectathon 11 Build •  Profiles on standard FHIR resources plus new

resource (Sequence) •  Enables EMR to obtain genetic results: both non-

sequence and sequence-based. •  Search-optimized GA4GH/raw sequence data •  Genomic data shadowing/constraints/mappings

Page 22: Building(Partnershipsfor(( Precision(Medicine...Precision medicine is an emerging approach for disease treatment and prevention that takes into account individual variability in genes,

SMART on FHIR Genomics: Clinico-Genomic Apps

SMART on FHIR Clinico-Genomics Apps

Sequencing Lab

EMR System

FHIR Data Report

Sequence …

Diagnostic Reporter App Diagnostic Order App

FHIR Data Order

Demographics Sequence

Order Genetics Labs

1

2 Return Genetics Labs Results

3 Present & Contextualize Genetics Labs Results

SMART Precision Cancer Medicine App (Warner, et al, JAMIA, 2016)

22  

Page 23: Building(Partnershipsfor(( Precision(Medicine...Precision medicine is an emerging approach for disease treatment and prevention that takes into account individual variability in genes,

Diagnostic Order App

PCM App (at Point of Care)

Diagnostic Reporter App

SMART on FHIR Genomics LAB

SMART Services

HL7 FHIR Genomics GA4GH

SMART on FHIR EMR

SMART Services

HL7 FHIR Genomics EMR

SMART on FHIR Genomics API

Server + Sandbox

1

2

3

23

Clinical data

Order

Order Response

Genomic data

CG Data

Source: Gil Alterovitz, SMART-on-FHIR Genomics

Page 24: Building(Partnershipsfor(( Precision(Medicine...Precision medicine is an emerging approach for disease treatment and prevention that takes into account individual variability in genes,

® Health  Level  Seven  and  HL7  are  registered  trademarks  of  Health  Level  Seven  Interna;onal,  registered  with  the  United  States  Patent  and  Trademark  Office.   24  

Krauss JC, et al. Data Sharing to Support the Cancer Journey in the Digital Era. Journal of oncology practice. 2016.

Org. support SMART/FHIR

Org. pilots of SMART/FHIR

SMART  on  FHIR  Pilots  for  Precision  Medicine  in  Cancer  

Page 25: Building(Partnershipsfor(( Precision(Medicine...Precision medicine is an emerging approach for disease treatment and prevention that takes into account individual variability in genes,

® Health  Level  Seven  and  HL7  are  registered  trademarks  of  Health  Level  Seven  Interna;onal,  registered  with  the  United  States  Patent  and  Trademark  Office.  

Precision  Cancer  Medicine  (PCM)  App  Warner  &  Alterovitz  

DB  (Diabetes  Bear)  EMR  App    Alterovitz  &  Yang  

Genomics  Advisor  App  Alterovitz  &  Zhang  

25  

Alterovitz G, et al. SMART on FHIR Genomics: facilitating standardized clinico-genomic apps. JAMIA. 2015;22(6):1173-8.

Page 26: Building(Partnershipsfor(( Precision(Medicine...Precision medicine is an emerging approach for disease treatment and prevention that takes into account individual variability in genes,

26  

https://gallery.smarthealthit.org

Genomics Category

SMART Precision Cancer Medicine

Genomics Advisor V2

Page 27: Building(Partnershipsfor(( Precision(Medicine...Precision medicine is an emerging approach for disease treatment and prevention that takes into account individual variability in genes,

27  

https://gallery.smarthealthit.org

Page 28: Building(Partnershipsfor(( Precision(Medicine...Precision medicine is an emerging approach for disease treatment and prevention that takes into account individual variability in genes,

28  

Domain  Analysis  Model  (DAM)  for  Clinical  Genomics,  Use  Cases:    1.  Specimen  IdenOficaOon  2.  Clinical  Sequencing  (Germline)  3.  Cancer  Profiling  (SomaOc)  4.  CDS  (Family  History  and  Drug  Dosage  Calculator)  5.  Public  Health  ReporOng  6.  Clinical  and  Research  Data  Warehouses  ...  

Alterovitz,  et  al.,  Domain  Analysis  Model:  Clinical  Genomics,  2016.

Page 29: Building(Partnershipsfor(( Precision(Medicine...Precision medicine is an emerging approach for disease treatment and prevention that takes into account individual variability in genes,

Fast  Healthcare  Interoperability  Resources  

Clinical  data  

Resource  

Resource  

Resource  

Resource  

Extension   Profile  

ApplicaOons  

Concise,  easily  understood  specificaLons  Well-­‐defined  data  model  and  API  Easy  to  implement  Modern  (RESTFul  API,  JSON,  Oauth)  Extensibile  

29

Page 30: Building(Partnershipsfor(( Precision(Medicine...Precision medicine is an emerging approach for disease treatment and prevention that takes into account individual variability in genes,

 Added  

6  GeneLcs  Profiles  

+  1  

Sequence  Resource  

Connectathon  11  

Jan  2016  

Current  Build  

Dec  2015  

DSTU2  

Sep  2015  

Added

1 Genetics Profile

 ObservaOon  Resource  

FHIR  Genomics  Time  Line  

30

STU  3  

Jul  2016  

 Connectathon  

&  Workgroup  Feedback  

+  Future  Work  

 Connectathon,    Pilots,    and    Test  scripts  

DSTU = Draft Standard for Trial Use STU = Standard for Trial Use

Page 31: Building(Partnershipsfor(( Precision(Medicine...Precision medicine is an emerging approach for disease treatment and prevention that takes into account individual variability in genes,

31  

FHIR  Genomics  +  

SMART  on  FHIR  Sep  2015  

Recommendation Actions to Advance

FHIR could be included as an emerging standard, especially for transport of data. Argonaut may provide opportunities to advance. Sample uses of FHIR: authorization; genetics, family health history, build on current work on SMART on FHIR Genomics1

Apply accelerators (e.g., S&I Initiative, pilot project, policy guidance) to existing standards by ONC

Recommendation Actions to Advance

2016 PMI S&I: Additional ONC investment in pilots of FHIR for PMI research/individual data donation use case

Apply accelerators (e.g., S&I Initiative, pilot project, policy guidance) to existing standards by ONC

1 Alterovitz G, et al. SMART on FHIR Genomics: facilitating standardized clinico-genomic apps. JAMIA. 2015;22(6):1173-8.

Page 32: Building(Partnershipsfor(( Precision(Medicine...Precision medicine is an emerging approach for disease treatment and prevention that takes into account individual variability in genes,

32  

ObservaLon  1  

Clinic  info  1        

Sequence  1  

ObservaLon  2  

Clinic  info  2  

Sequence  2   Sequence  3  

   Clinical  context  1:  condiLon,  paLent,…  

DiagnosLcReport  1  

Integrated into Clinical Data Model and Workflow

Page 33: Building(Partnershipsfor(( Precision(Medicine...Precision medicine is an emerging approach for disease treatment and prevention that takes into account individual variability in genes,

GeneOcs  Test:  Lab  (Code)  Only    

33

Observation

FamilyMemberHistory Genetic Profiles

Introduce Links

DiagnosticReport

DiagnosticOrder

Page 34: Building(Partnershipsfor(( Precision(Medicine...Precision medicine is an emerging approach for disease treatment and prevention that takes into account individual variability in genes,

GeneOcs  Test:  Lab  (Code)  +  Sequence  Data    

34

Observation

FamilyMemberHistory

Genetic Profiles

DiagnosticReport

DiagnosticOrder

Sequence Resource SMALL kilobyte DNA or RNA or AA Germline / Somatic

Page 35: Building(Partnershipsfor(( Precision(Medicine...Precision medicine is an emerging approach for disease treatment and prevention that takes into account individual variability in genes,

GeneOcs  Test:  Lab  (Code)  +  Sequence  Data  +  External  

Genetic Profiles

SMALL kilobyte DNA or RNA or AA Sequence Resource

DiagnosticReport

DiagnosticOrder FamilyMemberHistory

Observation

Full Sequence Source – eg, GA4GH BIG terabyte

Germline / Somatic

35  

Page 36: Building(Partnershipsfor(( Precision(Medicine...Precision medicine is an emerging approach for disease treatment and prevention that takes into account individual variability in genes,
Page 37: Building(Partnershipsfor(( Precision(Medicine...Precision medicine is an emerging approach for disease treatment and prevention that takes into account individual variability in genes,

® Health  Level  Seven  and  HL7  are  registered  trademarks  of  Health  Level  Seven  Interna;onal,  registered  with  the  United  States  Patent  and  Trademark  Office.  

AcLvely  working  on  pilots  

NaLonal  and  InternaLonal:    §  MGH/Hughes  RiskApps  §  Cerner  §  Intermountain  §  GRIN  (BCH/HMS,  CHOP,  Univ.  of  CincinnaO)  §  Vanderbilt  University  §  NaOonal  Marrow  Donor  Program  /  BeTheMatch  §  Precision  Link  §  Genospace  §  Allscripts/Nant  Health  §  Partners/GeneInsight/Medseq  §  Hefei  InsOtute  of  Technology  in  China  §  Google  (BCH/HMS)  §  DNA  Nexus/PrecisionFDA  §  TBResist  

Global  Alliance  federated  queries  SMART  on  FHIR  Genomics  server:    §  StraOfied  Medicine  Scotland  InnovaOon  Centre  §  UCSC  §  Royal  Melbourne  Hospital  &  Biogrid  Australia  §  Beijing  InsOtute  of  GeneOcs,  Chinese  Academy  of  

Science  §  EMC  R&D  §  Wellcome  Trust  Centre  for  Human  GeneOcs  §  Harvard/MIT  §  Aridhia  InformaOcs  §  Australia-­‐  Health  IntersecOons  

   

37

Page 38: Building(Partnershipsfor(( Precision(Medicine...Precision medicine is an emerging approach for disease treatment and prevention that takes into account individual variability in genes,

® Health  Level  Seven  and  HL7  are  registered  trademarks  of  Health  Level  Seven  Interna;onal,  registered  with  the  United  States  Patent  and  Trademark  Office.  

Building  Partnerships  for  Precision  Medicine:      FHIR  Genomics  Pilots  

§  1.  Pharmacogenomic  clinic:  Precision  Link  –  Precision Link is the first the exclusively Pharmacogenomic clinic in the world.  It

already has around 40 providers actively using it.   

§  2.  Precision  Medicine  for  global  health:  TBResist  –  This effort combines clinico-genomic data from over 20 countries for diagnostics and

therapeutics for drug resistant tuberculosis- to enable targeted patient approaches.  Consortium also was founded by Dale Nordenberg (former CIO of CDC).

§   3.  Precision  Medicine  Cloud  CompuLng:  DNA  Nexus/PrecisionFDA    –  DNA Nexus set up the precisionFDA portal (for testing genetic tests submitted to FDA)

and working on setting up FHIR Genomics server/apps on their platform.

38

Page 39: Building(Partnershipsfor(( Precision(Medicine...Precision medicine is an emerging approach for disease treatment and prevention that takes into account individual variability in genes,

Fhirgenomics.org  

39  

Follow  at:  @Fhirgenomics  

Page 40: Building(Partnershipsfor(( Precision(Medicine...Precision medicine is an emerging approach for disease treatment and prevention that takes into account individual variability in genes,

40  

Gil  Alterovitz    

[email protected]    

LinkedIn  Contact:  Follow  at:    @nirgenomics  

Handout:  

Page 41: Building(Partnershipsfor(( Precision(Medicine...Precision medicine is an emerging approach for disease treatment and prevention that takes into account individual variability in genes,

® Health  Level  Seven  and  HL7  are  registered  trademarks  of  Health  Level  Seven  Interna;onal,  registered  with  the  United  States  Patent  and  Trademark  Office.  

Acknowledgments  

   HL7  IOM  eMERGE  GA4GH  IGNITE  IEEE    SMART  on  FHIR  

 Ken  Mandl,  Isaac  Kohane,  David  Kreda,  Rachel  Ramoni,  Josh  Mandel...    SMART  on  FHIR  Genomics  

 Yao  Hemming,  Tom  Chen,  Peijin  Zhang...                  

41